Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05416229

Organisation Name: Psychiatric Centre Rigshospitalet

Overal Status: Not yet recruiting

Start Date: October 2022

Last Update: September 2, 2022

Lead Sponsor: Anders Fink-Jensen, MD, DMSci

Brief Summary: Note: The trial is only eligible for citizens of Denmark.

The purpose of this project is to assess the treatment efficacy of a single high dose of psilocybin administered within a protocol of psychological support to patients diagnosed with alcohol use disorder (AUD).

Conditions:
  • Alcohol Use Disorder


Total execution time in seconds: 0.20902705192566